{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:19:13Z","timestamp":1794277153393,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001852","name":"CEFIPRA","doi-asserted-by":"publisher","award":["5303-2"],"award-info":[{"award-number":["5303-2"]}],"id":[{"id":"10.13039\/501100001852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116289","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T07:26:00Z","timestamp":1709709960000},"page":"116289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens"],"prefix":"10.1016","volume":"173","author":[{"given":"Mohmmad","family":"Imran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Naiyaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atri","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan Singh","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh D.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav N.","family":"Mugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-0397","authenticated-orcid":false,"given":"Evgeny","family":"Apartsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Majoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-1904","authenticated-orcid":false,"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2024.116289_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129073","article-title":"Prevalence of non-tuberculosis mycobacterial infections among tuberculosis suspects in Iran: systematic review and meta-analysis","volume":"10","author":"Nasiri","year":"2015","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.biopha.2024.116289_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","article-title":"Environmental sources of nontuberculous mycobacteria","volume":"36","author":"Falkinham","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"8","key":"10.1016\/j.biopha.2024.116289_bib3","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3390\/jcm9082541","article-title":"General overview of nontuberculous mycobacteria opportunistic pathogens: mycobacterium avium and mycobacterium abscessus","volume":"9","author":"To","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2024.116289_bib4","unstructured":"Nontuberculous Mycobacteria (NTM) Infections | HAI | CDC Available online: https:\/\/www.cdc.gov\/hai\/organisms\/nontuberculous-mycobacteria.html."},{"key":"10.1016\/j.biopha.2024.116289_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00303","article-title":"The rise of non-tuberculosis mycobacterial lung disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116289_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-3-031-15955-8_26","article-title":"Drug discovery for non-tuberculous mycobacteria: recent updates","author":"Ahmad","year":"2023","journal-title":"Integr. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116289_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-019-0901-z","article-title":"Prevalence, Incidence & mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study","volume":"19","author":"Park","year":"2019","journal-title":"BMC Pulm. Med."},{"issue":"02","key":"10.1016\/j.biopha.2024.116289_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0035-1546751","article-title":"Nontuberculous mycobacteria in cystic fibrosis and non\u2013cystic fibrosis bronchiectasis","volume":"36","author":"Park","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116289_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/thoraxjnl-2012-201772","article-title":"Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis","volume":"68","author":"Andr\u00e9jak","year":"2012","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.biopha.2024.116289_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3201\/eid2203.151643","article-title":"Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease","volume":"22","author":"Raju","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116289_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejim.2015.03.001","article-title":"Multidrug-resistant tuberculosis\u201d may be nontuberculous mycobacteria","volume":"26","author":"Shahraki","year":"2015","journal-title":"Eur. J. Intern. Med."},{"issue":"12","key":"10.1016\/j.biopha.2024.116289_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00564-22","article-title":"In vitro and in vivo activity of gepotidacin against drug-resistant mycobacterial infections","volume":"66","author":"Ahmad","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jmm.0.000198","article-title":"Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria","volume":"65","author":"Soni","year":"2016","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116289_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/microorganisms7030090","article-title":"Mycobacterium abscessus: environmental bacterium turned clinical nightmare","volume":"7","author":"Lopeman","year":"2019","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.biopha.2024.116289_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pulmoe.2017.12.005","article-title":"Non-tuberculous mycobacterial pulmonary infections","volume":"24","author":"Chalmers","year":"2018","journal-title":"Pulmonology"},{"key":"10.1016\/j.biopha.2024.116289_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcsw.2020.100044","article-title":"Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall","volume":"6","author":"Batt","year":"2020","journal-title":"Cell Surf."},{"issue":"17","key":"10.1016\/j.biopha.2024.116289_bib17","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.3390\/molecules25173982","article-title":"Applications and limitations of dendrimers in biomedicine","volume":"25","author":"Chis","year":"2020","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.biopha.2024.116289_bib18","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/molecules24162894","article-title":"Synergistic effects of anionic\/cationic dendrimers and levofloxacin on antibacterial activities","volume":"24","author":"Wro\u0144ska","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.biopha.2024.116289_bib19","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1021\/acs.biomac.3c00266","article-title":"Low-generation cationic phosphorus dendrimers: novel approach to tackle drug-resistant S. Aureus in Vitro and in Vivo","volume":"24","author":"Apartsin","year":"2023","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.biopha.2024.116289_bib20","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/acs.biomac.1c00355","article-title":"Safe polycationic dendrimers as potent oral in vivo inhibitors of Mycobacterium Tuberculosis: a new therapy to take down tuberculosis","volume":"22","author":"Mignani","year":"2021","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.biopha.2024.116289_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijantimicag.2019.03.024","article-title":"Repurposing disulfiram for treatment of Staphylococcus aureus infections","volume":"53","author":"Thakare","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2024.116289_bib22","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/jac\/dkx277","article-title":"Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections","volume":"72","author":"Singh","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2024.116289_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, Antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/AAC.01035-09","article-title":"Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure","volume":"54","author":"Malik","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00042","article-title":"Variation in mutant prevention concentrations","volume":"10","author":"Gianvecchio","year":"2019","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116289_bib26","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1128\/AAC.02459-14","article-title":"Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpene","volume":"58","author":"Kathuria","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib27","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1128\/AAC.48.12.4550-4555.2004","article-title":"Rapid, simple In Vivo Screen For New Drugs Active Against Mycobacterium Tuberculosis","volume":"48","author":"Nikonenko","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/jac\/dkz018","article-title":"Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria","volume":"74","author":"Das","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2024.116289_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01879-19","article-title":"Dissecting erm (41)-mediated macrolide-inducible resistance in mycobacterium abscessus","volume":"64","author":"Richard","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.116289_bib31","unstructured":"Krohn, T.B. Combination antibiotic testing: When 2 drugs are better than 1 (or 2) https:\/\/asm.org\/Articles\/2018\/September\/Combination-Antibiotic-Testing-When-2-Drugs-are-Be."},{"issue":"8","key":"10.1016\/j.biopha.2024.116289_bib32","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/AAC.00474-11","article-title":"Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen","volume":"55","author":"Ram\u00f3n-Garc\u00eda","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.biopha.2024.116289_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2024.116289_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tube.2019.03.004","article-title":"Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin","volume":"115","author":"Patel","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.biopha.2024.116289_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mib.2020.05.012","article-title":"How antibiotics work together: molecular mechanisms behind combination therapy","volume":"57","author":"Sullivan","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116289_bib36","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.3390\/molecules26123708","article-title":"First-in-class phosphorus dendritic framework, a wide surface functional group palette bringing noteworthy anti-cancer and anti-tuberculosis activities: what lessons to learn?","volume":"26","author":"Mignani","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2024.116289_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.drudis.2020.11.034","article-title":"In vivo therapeutic applications of phosphorus dendrimers: state of the art","volume":"26","author":"Mignani","year":"2021","journal-title":"Drug Discov. Today"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:23:04Z","timestamp":1793787784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":37,"alternative-id":["S0753332224001707"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116289","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116289"}}